Research programme: cGAS/STING antagonists - X-37
Latest Information Update: 12 Oct 2020
At a glance
- Originator X-37
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Nucleotidyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders; Systemic lupus erythematosus
Most Recent Events
- 24 Sep 2020 Early research in Autoimmune disorders in USA (unspecified route) (X-37 pipeline, September 2020)
- 24 Sep 2020 Early research in Systemic lupus erythematosus in USA (unspecified route) (X-37 pipeline, September 2020)
- 24 Sep 2020 X-37 plans a Clinical trial for Cancer in 2022